Skin Research Institute of Singapore

Tackling Eczema

Atopic Dermatitis (AD) or eczema is a dry, itchy, rash-like inflammatory skin disorder that affects up to 20% of the population in developed countries. It reduces the quality of life for patients and their caretakers in many ways including loss of sleep, school and work absences, restrictions on clothing, body products, physical activity and low self-esteem.

To tackle this, the Skin Research Institute of Singapore (SRIS) set up the National Atopic Dermatitis Programme. By bringing together leading researchers, industry partners and end-users to focus on the underlying causes of AD, the team aims to improve health outcomes for patients and translate these into improved practices and therapies.